Asahiro Morishita, Joji Tani, Takako Nomura, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Tingting Shi, Hiroki Yamana, et al. Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study. Cancers. 2021. 13. 18
Shima Mimura, Koji Fujita, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Hideki Kobara, Joji Tani, Asahiro Morishita, Takashi Himoto, et al. Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAg. Internal and emergency medicine. 2021. 16. 6. 1559-1565
Kyoko Oura, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Asahiro Morishita, Hideki Kobara, Tsutomu Masaki. Multimodal treatment involving molecular targeted agents and on-demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report and review of the literature. Molecular and clinical oncology. 2021. 15. 2. 154-154
Tomoko Tadokoro, Koji Fujita, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Teppei Sakamoto, Takako Nomura, Joji Tani, Asahiro Morishita, et al. Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up. Internal medicine (Tokyo, Japan). 2021. 60. 12. 1835-1838
Asahiro Morishita, Kei Nomura, Joji Tani, Koji Fujita, Hisakazu Iwama, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Kyoko Oura, Taiga Chiyo, et al. Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo. Oncology reports. 2021. 45. 6
